cell-therapy

Documents about cell-therapy

• Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma#837373ClinicalTrials.gov
• Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer#864924ClinicalTrials.gov
• Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck#852967ClinicalTrials.gov
• Pharmacogenomics of treatment toxicities in pediatric B-Cell ALL: toward safer precision therapy#274395HAL (France)
• Photobiomodulation therapy to prevent oral mucositis and functional impairment in adult patients with haematological cancer undergoing haematopoietic stem cell transplantation: randomised trial protocol#428463Repositorio Universidad del Desarrollo
• Biomimetic membrane-coated metal nanoplatforms for enhanced BBB penetration and targeted glioblastoma therapy#642642Europe PMC
• Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction#857256ClinicalTrials.gov
• Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma#865316ClinicalTrials.gov
• Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence#801079ClinicalTrials.gov
• Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma#154648ClinicalTrials.gov
• Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation#123460ClinicalTrials.gov
• Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19#127782ClinicalTrials.gov
• Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy#140975ClinicalTrials.gov
• Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL#172322ClinicalTrials.gov
• Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor#180395ClinicalTrials.gov
• Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)#181762ClinicalTrials.gov
• Stromal Cell–Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer#187185Zenodo (CERN)
• Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma#230398ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer#287372ClinicalTrials.gov
• Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T-cell therapy#292625OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)#321709ClinicalTrials.gov
• Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors#329524ClinicalTrials.gov
• Combining gene and stem cell therapy in the treatment of dysferlinophaties#392064IRIS
• Human neural stem cell-derived extracellular vesicles improve cognitive function following glioma chemoradiation therapy.#442865NCBI PubMed Central
• Harvest, Isolation and Culture of Cardiac Stem Cells From Endomyocardial Biopsies#806218ClinicalTrials.gov
• Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma#810759ClinicalTrials.gov
• Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer#833262ClinicalTrials.gov
• Immunotherapy Treating GI Cancer#840663ClinicalTrials.gov
• The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey#846161ClinicalTrials.gov
• Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy#861678ClinicalTrials.gov
• Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer#840235ClinicalTrials.gov
• Lymphocyte recovery after bendamustine therapy in patients with mantle cell lymphoma. Results of a retrospective analysis and prognostic impact in the CAR-T era#312158IRIS
• Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer#812838ClinicalTrials.gov
• Quantifying Systemic Immunosuppression to Personalize Cancer Therapy#851374ClinicalTrials.gov
• The role of pathology in immunotherapy and targeted therapy for renal cell carcinoma#268874IRIS
• Nanomedicine Meets Immunotherapy: Transforming Chimeric Antigen Receptor T Cell Treatment for Solid Tumors#277899Scholar Commons
• Stem Cell Therapy for Traumatic Brain Injury: Translational Mechanisms, Biomarkers, and Clinical Trials#359194Springer Nature OA
• Stem Cell and Growth Factor Injury and Arthritis Clinical Research Study#810298ClinicalTrials.gov
• Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer#825830ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma#827794ClinicalTrials.gov
• Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations#850011ClinicalTrials.gov
• Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy#860111ClinicalTrials.gov
• Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma#158108ClinicalTrials.gov
• Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer#800663ClinicalTrials.gov
• Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN#307446ClinicalTrials.gov
• Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma#846912ClinicalTrials.gov
• Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung#831988ClinicalTrials.gov
• Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma#252976ClinicalTrials.gov
• Autologous adipose stem cell therapy for knee osteoarthritis: where are we now?#284492IRIS
• A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers#373584ClinicalTrials.gov